GARFIELD-AF: A WORLDWIDE PROSPECTIVE REGISTRY OF PATIENTS WITH ATRIAL FIBRILLATION AT RISK OF STROKE ArticleSawhney J.P.S., Heuzey J.Y.L., Koretsune Y., Jerjes-Sanchez C., Hacke W., Goto S., Fox K.A.A., Haas S., Camm A.J., Atar D., Kayani G., Pieper K.S., Kakkar A.K., Garfield-Af Investigators F.T., Bassand J.P., Verheugt F.W.A., Cate V.T., Stepinska J., Apenteng P.N., Fitzmaurice D.A. ...Future Cardiology. Том 17. 2021. С. 19-38
CHANGES IN ANTICOAGULANT PRESCRIPTION IN DUTCH PATIENTS WITH RECENT-ONSET ATRIAL FIBRILLATION: OBSERVATIONS FROM THE GARFIELD-AF REGISTRY ArticleSeelig J., Hemels M.E.W., Verheugt F.W.A., Illingworth L., Pieper K., Lucassen A., Adriaansen H., Bongaerts M.C.M., Pieterse M., Herrman J.P.R., Hoogslag P., Hermans W., Groenemeijer B.E., Boersma L.V.A., Ten Cate H.Thrombosis Journal. Том 18. 2020. 5 с.
ANTITHROMBOTICS: FROM ASPIRIN TO DOACS IN CORONARY ARTERY DISEASE AND ATRIAL FIBRILLATION (PART 3/5) ArticleVerheugt F.W.A., Ten Berg J.M., Storey R.F., Cuisset T., Granger C.B.Journal of the American College of Cardiology. Том 74. 2019. С. 699-711